Prospective study of CAM 17·1/WGA mucin assay for serological diagnosis of pancreatic cancer-Reference-Cited by-同舟云学术

Prospective study of CAM 17·1/WGA mucin assay for serological diagnosis of pancreatic cancer

Published:1997-02 Issue:9049 Volume:349 Page:389-392
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Yiannakou JY,Newland P,Calder F,Kingsnorth AN,Rhodes Jonathan M

Publisher

Elsevier BV

Subject

General Medicine

Reference14 articles.

1. Comparison of the sensitivity and specificity of the CA 19–9 and carcinoembryonic antigen assays in detecting cancer of the pancreas;Steinberg;Am J Gastroenterol,1986

2. Determination of CA 19–9 antigen in serum and pancreatic juice for differential diagnosis of pancreatic adenocarcinoma from chronic pancreatitis;Malesci;Gastroenterology,1987

3. Evaluation of CA-19-9 as a tumour marker in pancreatic cancer;Haglund;Br J Gancer,1986

4. Tumour markers in pancreatic cancer: a comparative clinical study between CEA, CA 19-9 and CA 50;Molina;Int J Biol Markers,1990

5. An evaluation of DUPAN-2 in pancreatic cancer and gastrointestinal disease;Cooper;Br J Cancer,1990

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cellular Components Contributing to the Development of Venous Thrombosis in Patients with Pancreatic Cancer;Seminars in Thrombosis and Hemostasis;2023-12-04

2. Plasma Metabolite Biomarkers for the Detection of Pancreatic Cancer;Journal of Proteome Research;2014-12-08

3. Molecular Diagnostics of Pancreatic Cancer;Molecular Pathology and Diagnostics of Cancer;2013-09-06

4. Glycoproteomic strategies: From discovery to clinical application of cancer carbohydrate biomarkers;PROTEOMICS - Clinical Applications;2013-08-06

5. A Novel Serum Metabolomics-Based Diagnostic Approach to Pancreatic Cancer;Cancer Epidemiology Biomarkers & Prevention;2013-04